These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 22055384)

  • 21. Stress, cortisol and well-being of caregivers and children in home-based child care: a case for differential susceptibility.
    Groeneveld MG; Vermeer HJ; van IJzendoorn MH; Linting M
    Child Care Health Dev; 2012 Mar; 38(2):251-60. PubMed ID: 21166835
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Management of Acute Adrenal Insufficiency-Related Adverse Events in Children with Congenital Adrenal Hyperplasia: Results of an International Survey of Specialist Centres.
    Ali SR; Bryce J; Krone NP; Claahsen-van der Grinten HL; Ahmed SF
    Horm Res Paediatr; 2022; 95(4):363-373. PubMed ID: 35569445
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Impact of hydrocortisone on adult height in congenital adrenal hyperplasia-the Minnesota cohort.
    Sarafoglou K; Addo OY; Turcotte L; Otten N; Wickremasinghe A; Pittock S; Kyllo J; Lteif AN; Himes JH; Miller BS
    J Pediatr; 2014 May; 164(5):1141-1146.e1. PubMed ID: 24560184
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Somatic development in a group of 59 children with congenital adrenal hyperplasia in relation to therapy].
    Lisá L
    Cesk Pediatr; 1989 Dec; 44(12):712-3. PubMed ID: 2636554
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Audit of management of children and adolescents with congenital adrenal hyperplasia as per recent Endocrine Society guidelines.
    S L; Krishna Prasad H; Ramjee B; Venugopalan L; Ganapathy N; Paramasamy B
    Pediatr Endocrinol Diabetes Metab; 2023; 29(1):10-15. PubMed ID: 36734395
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Caregiver self-efficacy for managing behavioural problems of older people with dementia in Taiwan correlates with care receivers' behavioural problems.
    Huang HL; Shyu YI; Chen ST; Hsu WC
    J Clin Nurs; 2009 Sep; 18(18):2588-95. PubMed ID: 19207803
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of the dose of oral hydrocortisone on growth rate during long-term treatment of children with salt losing congenital adrenal hyperplasia.
    Ciaccio M; Montiveros C; Rivarola MA; Belgorosky A
    Medicina (B Aires); 2002; 62(6):551-4. PubMed ID: 12532689
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Determinants of antipyretic misuse in children up to 5 years of age: a cross-sectional study.
    Bilenko N; Tessler H; Okbe R; Press J; Gorodischer R
    Clin Ther; 2006 May; 28(5):783-93. PubMed ID: 16861100
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Salivary cortisol, stress, and health in primary caregivers (mothers) of children with cerebral palsy.
    Bella GP; Garcia MC; Spadari-Bratfisch RC
    Psychoneuroendocrinology; 2011 Jul; 36(6):834-42. PubMed ID: 21146316
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Control of child development as the basis of monitoring the treatment of congenital adrenal hyperplasia].
    Rybakowa M; Sołtysik-Wilk E
    Folia Med Cracov; 1986; 27(1-2):3-8. PubMed ID: 3732956
    [No Abstract]   [Full Text] [Related]  

  • 31. Congenital adrenal hyperplasia--pharmacologic interventions from the prenatal phase to adulthood.
    Claahsen-van der Grinten HL; Stikkelbroeck NM; Otten BJ; Hermus AR
    Pharmacol Ther; 2011 Oct; 132(1):1-14. PubMed ID: 21635919
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The child with difficult to control Congenital Adrenal Hyperplasia: is there a place for continuous subcutaneous hydrocortisone therapy.
    Hindmarsh PC
    Clin Endocrinol (Oxf); 2014 Jul; 81(1):15-8. PubMed ID: 24655023
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Health care utilization and needs after pediatric traumatic brain injury.
    Slomine BS; McCarthy ML; Ding R; MacKenzie EJ; Jaffe KM; Aitken ME; Durbin DR; Christensen JR; Dorsch AM; Paidas CN;
    Pediatrics; 2006 Apr; 117(4):e663-74. PubMed ID: 16533894
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Management of altered hydrocortisone pharmacokinetics in a boy with congenital adrenal hyperplasia using a continuous subcutaneous hydrocortisone infusion.
    Bryan SM; Honour JW; Hindmarsh PC
    J Clin Endocrinol Metab; 2009 Sep; 94(9):3477-80. PubMed ID: 19567522
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Timing and type of glucocorticoid replacement in adult congenital adrenal hyperplasia.
    Ross RJ; Rostami-Hodjegan A
    Horm Res; 2005; 64 Suppl 2():67-70. PubMed ID: 16286775
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Variation in absorption and half-life of hydrocortisone influence plasma cortisol concentrations.
    Hindmarsh PC; Charmandari E
    Clin Endocrinol (Oxf); 2015 Apr; 82(4):557-61. PubMed ID: 25369980
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Psychiatric manifestations in young females with congenital adrenal hyperplasia in Taiwan.
    Liang HY; Chang HL; Chen CY; Chang PY; Lo FS; Lee LW
    Chang Gung Med J; 2008; 31(1):66-73. PubMed ID: 18419055
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Caregiver strain and factors associated with caregiver self-efficacy and quality of life in a community cohort with multiple sclerosis.
    Khan F; Pallant J; Brand C
    Disabil Rehabil; 2007 Aug; 29(16):1241-50. PubMed ID: 17653999
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Screening for Anxiety and Depression in Children with Congenital Adrenal Hyperplasia.
    Jacob M; Lin-Su K; Catarozoli C; Thomas C; Poppas D; Lekarev O
    J Clin Res Pediatr Endocrinol; 2023 Nov; 15(4):406-416. PubMed ID: 37470306
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Management of Childhood Congenital Adrenal Hyperplasia-An Integrative Review of the Literature.
    Fleming L; Van Riper M; Knafl K
    J Pediatr Health Care; 2017; 31(5):560-577. PubMed ID: 28416079
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.